Guardant Health Wins 2026 Prix Galien USA Medical Technology Award
Guardant Health said its Shield blood test for colorectal cancer was recognized for its impact in increasing screening participation.
Related stories
Apollo Global Management Shares Fall 5% After Q3 Revenue, Adjusted EPS Miss Estimates
Apollo Global Management shares are down 5% after third-quarter revenue and adjusted EPS missed estimates.
M impact | EQUITY | Nov 03, 2026, 02:38 PM UTC
Revvity Shares Rise 11.4% After Q3 Revenue Beat, Guidance Raise
Revvity shares hit their highest level since April 2022 after the company reported a third-quarter revenue beat and raised full-year guidance.
M impact | EQUITY | Nov 03, 2026, 02:37 PM UTC
Keurig Dr Pepper Shares Fall About 4% on Slower Coffee Growth
The company flagged slower-than-expected growth in its US coffee segment for Q4.
M impact | EQUITY | Nov 03, 2026, 02:37 PM UTC
Volaris Shares Rise 10% at the Open
M impact | EQUITY | Nov 03, 2026, 02:36 PM UTC
Upwork raises annual adjusted profit forecast; shares rise 2.7%
M impact | EQUITY | Nov 03, 2026, 02:36 PM UTC
Proto Labs Raises Multi Jet Fusion 3D Printing Capacity by 50%
Proto Labs said it raised its HP Multi Jet Fusion 3D-printing capacity by 50%.
M impact | EQUITY | Nov 03, 2026, 02:36 PM UTC